申请人:Egis Gyogyszergyar
公开号:US04665083A1
公开(公告)日:1987-05-12
The invention relates to novel iminothiazolidine derivatives of the formula (I), ##STR1## wherein R.sup.1 and R.sup.3 represent, independently from each other, hydrogen or lower alkyl group, R.sup.3 is nitro or amino group, R stands for halo, lower alkyl, haloalkyl, nitro, amino, hydroxy, lower alkoxy, carboxy or lower alkoxycarbonyl group, and n is 0, 1 or 2, and pharmaceutically acceptable acid addition salts thereof. The iminothiazolidine derivatives of the formula (I) possess valuable antidepressant, antiparkinsonic, antiepileptic and spasmolytic activities.
该发明涉及化合物的新型亚嘧啶硫代环己烷衍生物,其化学式为(I),
其中R.sup.1和R.sup.3分别独立表示氢或较低的烷基,R.sup.3为硝基或氨基,R代表卤素、较低的烷基、卤代烷基、硝基、氨基、羟基、较低的烷氧基、羧基或较低的烷氧羰基,n为0、1或2,以及其药学上可接受的酸盐。化合物的亚嘧啶硫代环己烷衍生物具有有价值的抗抑郁、抗帕金森、抗癫痫和解痉活性。